Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Dec. 28, 2024

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

Schedule II - Valuation And Qualifying Accounts

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

(in thousands)

Description	Balance at beginning of period		Charged to costs and expenses		Deductions		Balance at end of period
December 28, 2024
Allowance for sales returns	$	420	$	5,185	$	5,307	$	298
Allowance for credit losses	421		—		200		221
Valuation allowance - deferred tax assets	137,252		18,853		—		156,105
December 30, 2023
Allowance for sales returns	$	572	$	5,552	$	5,704	$	420
Allowance for credit losses	363		112		54		421
Valuation allowance - deferred tax assets	118,136		19,116		—		137,252
December 31, 2022
Allowance for sales returns	$	547	$	6,562	$	6,537	$	572
Allowance for credit losses	504		6		147		363
Valuation allowance - deferred tax assets	99,958		18,178		—		118,136